{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:25:37Z","timestamp":1779128737021,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1603602"],"award-info":[{"award-number":["2022YFA1603602"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009076","name":"University of Science and Technology of China","doi-asserted-by":"publisher","award":["2024-N(A)-0200"],"award-info":[{"award-number":["2024-N(A)-0200"]}],"id":[{"id":"10.13039\/501100009076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["YD9110002029"],"award-info":[{"award-number":["YD9110002029"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077116"],"award-info":[{"award-number":["22077116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113927","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T21:14:50Z","timestamp":1735074890000},"page":"113927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["c-JUN interacts with HDAC1 as a potential combinatorial therapeutic target in acute myeloid leukemia"],"prefix":"10.1016","volume":"146","author":[{"given":"Ke","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113927_b0005","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.113927_b0010","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3324\/haematol.2011.054734","article-title":"Recent advances in acute myeloid leukemia stem cell biology","volume":"97","author":"Horton","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.intimp.2024.113927_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15143583","article-title":"Current landscape of genome-wide association studies in acute myeloid leukemia: a review","volume":"15","author":"Marrero","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2024.113927_b0020","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1080\/10428194.2017.1344905","article-title":"The emerging role of immune checkpoint based approaches in AML and MDS","volume":"59","author":"Boddu","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.intimp.2024.113927_b0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fphar.2019.00609","article-title":"A review of efficacy and safety of checkpoint inhibitor for the treatment of acute myeloid leukemia","volume":"10","author":"Liao","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113927_b0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood-2014-10-551911","article-title":"How I treat refractory and early relapsed acute myeloid leukemia","volume":"126","author":"Thol","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.113927_b0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2015-08-604520","article-title":"An update of current treatments for adult acute myeloid leukemia","volume":"127","author":"Dombret","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.113927_b0040","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1002\/cncr.33156","article-title":"Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia","volume":"126","author":"Karol","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2024.113927_b0045","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s13046-022-02559-z","article-title":"The traditional chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun","volume":"41","author":"Yu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2024.113927_b0050","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1182\/blood-2008-10-183244","article-title":"Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility","volume":"113","author":"Knight","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.113927_b0055","doi-asserted-by":"crossref","first-page":"7891","DOI":"10.18632\/oncotarget.13631","article-title":"Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia","volume":"8","author":"Lv","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2024.113927_b0060","doi-asserted-by":"crossref","first-page":"34859","DOI":"10.18632\/oncotarget.26163","article-title":"Genome-wide association analysis identifies SNPs predictive of in vitro leukemic cell sensitivity to cytarabine in pediatric AML","volume":"9","author":"Bargal","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2024.113927_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.intimp.2024.113927_b0070","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrcardio.2017.78","article-title":"Mendelian randomization in cardiometabolic disease: challenges in evaluating causality","volume":"14","author":"Holmes","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2024.113927_b0075","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0140-6736(05)67767-7","article-title":"Nature's randomised trials","volume":"366","author":"Hingorani","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113927_b0080","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using Mendelian randomisation","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.113927_b0085","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2024.113927_b0090","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1093\/brain\/awad070","article-title":"Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis","volume":"146","author":"Lin","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2024.113927_b0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.aan6828","article-title":"Single-cell transcriptomics to explore the immune system in health and disease","volume":"358","author":"Stubbington","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.intimp.2024.113927_b0100","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.27041","article-title":"The human cell atlas","volume":"6","author":"Regev","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2024.113927_b0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13073-023-01241-z","article-title":"Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia","volume":"15","author":"Mumme","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.intimp.2024.113927_b0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13402-023-00853-2","article-title":"Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy","volume":"47","author":"Hu","year":"2024","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.intimp.2024.113927_b0115","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.113927_b0120","article-title":"Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy","author":"Hu","year":"2023","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.intimp.2024.113927_b0125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2024.113927_b0130","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s43018-023-00599-8","article-title":"Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer","volume":"4","author":"Zheng","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.intimp.2024.113927_b0135","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1038\/s41380-022-01507-9","article-title":"Identifying causal genes for depression via integration of the proteome and transcriptome from brain and blood","volume":"27","author":"Deng","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.intimp.2024.113927_b0140","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.intimp.2024.113927_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.919731","article-title":"Single-cell transcriptomics of proliferative phase endometrium: systems analysis of cell-cell communication network using cellchat","volume":"10","author":"Fang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2024.113927_b0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2024.113927_b0155","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.intimp.2024.113927_b0160","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/liv.15566","article-title":"Association between antihypertensive drugs and hepatocellular carcinoma: A trans-ancestry and drug-target Mendelian randomization study","volume":"43","author":"Wang","year":"2023","journal-title":"Liver Int."},{"key":"10.1016\/j.intimp.2024.113927_b0165","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cell.2018.05.013","article-title":"Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.113927_b0170","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1158\/2159-8290.CD-20-1145","article-title":"Epigenetic activation of plasmacytoid DCs drives IFNAR-dependent therapeutic differentiation of AML","volume":"12","author":"Salmon","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2024.113927_b0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccell.2021.11.002","article-title":"The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2024.113927_b0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s40425-019-0733-7","article-title":"Niclosamide, an antihelmintic drug, enhances efficacy of PD-1\/PD-L1 immune checkpoint blockade in non-small cell lung cancer","volume":"7","author":"Luo","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2024.113927_b0185","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1172\/JCI129049","article-title":"HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models","volume":"130","author":"Nguyen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.113927_b0190","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijrobp.2022.07.1832","article-title":"Accurate and early metastases diagnosis in live animals with multimodal X-ray and optical imaging","volume":"115","author":"Chen","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.intimp.2024.113927_b0195","doi-asserted-by":"crossref","first-page":"13122","DOI":"10.1038\/ncomms13122","article-title":"Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer","volume":"7","author":"He","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.113927_b0200","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/2326-6066.CIR-17-0212","article-title":"The immune checkpoint modulator OX40 and its ligand OX40L in NK-cell immunosurveillance and acute myeloid leukemia","volume":"6","author":"Nuebling","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2024.113927_b0205","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/sj.onc.1207192","article-title":"Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia","volume":"23","author":"Staber","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2024.113927_b0210","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ccr.2011.09.011","article-title":"Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia\/acute myeloid leukemia and identifies patients at risk","volume":"20","author":"Li","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2024.113927_b0215","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cell.2011.07.032","article-title":"AKT\/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias","volume":"146","author":"Sykes","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.113927_b0220","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/leu.2016.329","article-title":"JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia","volume":"31","author":"Zhou","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2024.113927_b0225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41419-022-04654-7","article-title":"Heterogeneity induced GZMA-F2R communication inefficient impairs antitumor immunotherapy of PD-1 mAb through JAK2\/STAT1 signal suppression in hepatocellular carcinoma","volume":"13","author":"Gao","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2024.113927_b0230","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.36","article-title":"Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets","volume":"6","author":"Maiga","year":"2016","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.intimp.2024.113927_b0235","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/bloodadvances.2018024182","article-title":"Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia","volume":"3","author":"Mitchell","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.intimp.2024.113927_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010209","article-title":"Targeting histone deacetylases: opportunities for cancer treatment and chemoprevention","volume":"14","author":"Ruzic","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2024.113927_b0245","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2024.113927_b0250","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/13543776.2020.1725470","article-title":"Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present)","volume":"30","author":"Zhao","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.intimp.2024.113927_b0255","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111794","article-title":"HDAC inhibitors in acute myeloid leukemia","volume":"11","author":"San Jos\u00e9-En\u00e9riz","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2024.113927_b0260","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acs.jmedchem.1c01472","article-title":"Potent hydrazide-based HDAC inhibitors with a superior pharmacokinetic profile for efficient treatment of acute myeloid leukemia in vivo","volume":"65","author":"Jiang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"2020","key":"10.1016\/j.intimp.2024.113927_b0265","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty years of HDAC inhibitors: 2020 insight and hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2024.113927_b0270","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1021\/acs.jmedchem.8b01597","article-title":"Discovery of novel janus kinase (JAK) and histone deacetylase (HDAC) dual inhibitors for the treatment of hematological malignancies","volume":"62","author":"Liang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2024.113927_b0275","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1158\/1535-7163.MCT-12-0129","article-title":"Breakdown of the FLT3-ITD\/STAT5 axis and synergistic apoptosis induction by the histone deacetylase inhibitor panobinostat and FLT3-specific inhibitors","volume":"11","author":"Pietschmann","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.intimp.2024.113927_b0280","article-title":"Evaluation of the antitumor effects of BPR1J-340, a potent and selective FLT3 inhibitor, alone or in combination with an HDAC inhibitor, vorinostat, in AML cancer","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.113927_b0285","first-page":"984","article-title":"Targeting of PI3K\/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance","volume":"4","author":"Estruch","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.intimp.2024.113927_b0290","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/bloodadvances.2021006152","article-title":"Genome-wide CRISPR\/Cas9 screening identifies determinant of panobinostat sensitivity in acute lymphoblastic leukemia","volume":"6","author":"Jiang","year":"2022","journal-title":"Blood Adv."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T16:55:00Z","timestamp":1736614500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924024494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":58,"alternative-id":["S1567576924024494"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113927","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"c-JUN interacts with HDAC1 as a potential combinatorial therapeutic target in acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113927"}}